Anticancer Agents Derived from Cyclic Thiosulfonates: Structure‐Reactivity and Structure‐Activity Relationships
作者:Amanda F. Ghilardi、Elham Yaaghubi、Renan B. Ferreira、Mary E. Law、Yinuo Yang、Bradley J. Davis、Christopher M. Schilson、Ion Ghiviriga、Adrian E. Roitberg、Brian K. Law、Ronald K. Castellano
DOI:10.1002/cmdc.202200165
日期:2022.7.19
Exchange dynamics: Reported are structure-property-function relationships of cyclic thiosulfonate molecules—disulfide-bond disrupting agents (DDAs)—that downregulate the Epidermal Growth Factor Receptor (HER) family in parallel and selectively induce apoptosis of EGFR+ or HER2+ breast cancer cells. Shown recently, the DDAs covalently bind to the active site cysteine residue(s) of selected protein disulfide
交换动态:据报道,环状硫代磺酸盐分子(二硫键破坏剂 (DDA))的结构-性质-功能关系,可同时下调表皮生长因子受体 (HER) 家族,并选择性诱导 EGFR+ 或 HER2+ 乳腺癌细胞凋亡。最近显示,DDA 与选定的蛋白质二硫键异构酶 (PDI) 的活性位点半胱氨酸残基共价结合。如图所示,DDA 的结构修饰可以调节硫醇-硫代磺酸盐交换反应的动力学,并产生更有效的化合物。